StockVS

NASDAQ · Shell Companies · USD

Translational Development Acquisition Corp. (TDAC) Stock Analysis

Translational Development Acquisition Corp. (TDAC) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

TDAC

$10.82

−$0.01 (−0.09%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare TDAC with… →

TDAC Key Statistics

As of Oct 21, 2026
Trading
Open
$10.81
Previous Close
$10.83
Day's Range
10.81–10.83
52-Week Range
10.41–10.95
Volume
6.46K
Valuation
Market Cap
$208.92M
P/E Ratio
41.62
EPS (ttm)Profit attributable to each share over the last twelve months.
0.26
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
$6.36M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
19.31M
1-Year Return
+3.44%
Dividend and dates
Avg Volume
28.91K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, TDAC closed at $10.82, +3.44% over 1 year.

Translational Development Acquisition Corp. (TDAC) has a market capitalization of $208.92M.

In fiscal 2025, TDAC reported revenue of $0.00.

TDAC Stock Return by Calendar Year

Translational Development Acquisition Corp. (TDAC) return since Feb 2025: what $10,000 became

1 year
$10,000 $10,344
+3.44%
Since Feb 2025
$10,000 $10,809
+8.09%

If you had invested $10,000 in Translational Development Acquisition Corp. (TDAC) at the close on February 13, 2025, the earliest close on record here, it would have been worth $10,809 at the close on October 21, 2026: +8.09% in total, +4.73% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+3.15%
2025 (partial year)+4.80%

As of October 21, 2026.

TDAC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00$6.36M—
2024$0.00−$71.01K—
2023$0.00−$485.55K—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$944.54K$6.36M—
2024$0.00—−$196.36K−$71.01K—
2023$0.00—−$485.55K−$485.55K—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

TDAC Valuation vs Shell Companies Median

Median of 309 stocks
MetricTDACShell Companies medianvs median
P/E41.6249.1615% below

Medians across 309 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Translational Development Acquisition Corp. (TDAC) at $208.92M. It is classified in the Shell Companies industry, within the Financial Services sector.

Over the past 52 weeks the price has ranged from $10.41 to $10.95. TDAC last closed at $10.82 on October 21, 2026. That is −$0.01 (−0.09%) against the previous close. The latest close sits 3.99% above that 52-week low.

Financial Health

In fiscal 2025, Translational Development Acquisition Corp. reported revenue of $0.00. Net income for the same year was $6.36M. Earnings per share on a trailing basis come to 0.26.

Across the 3 fiscal years on file, revenue moves from $0.00 in 2023 to $0.00 in 2025. Of those 3 years, 1 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 41.62. That is 15.33% below the Shell Companies median of 49.16. 309 Shell Companies companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is +3.44%. The stored price history starts on February 13, 2025, and the total return since then is +8.09%. Annualized volatility over the trailing 1 year is 2.5%.

Growth & Income

No dividend is on file for TDAC.

So far in 2026 the total return is +3.15%.

Peer Comparison

Translational Development Acquisition Corp. (TDAC) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Translational Development Acquisition Corp. TDAC $208.92M 41.6
Vylor Inc. VYLR $49.89B 106.8
Drugs Made In America Acquisition II Corp. DMII $649.10M 34.0
Churchill Capital Corp XI CCXI $621.61M —

The Shell Companies industry average P/E ratio is 49.2x. Translational Development Acquisition Corp. trades at a P/E of 41.6.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Shell Companies Stocks

View all Shell Companies stocks →

Popular Financial Services Stocks

View all Financial Services stocks →

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Visit website →